1. Home >
  2. M&A >
  3. Divestiture >
  4. Australia >
  5. Sanofi Acquires Symbion CP Holdings Pty

M&A Deal Summary

Sanofi Acquires Symbion CP Holdings Pty

On July 21, 2008, Sanofi acquired consumer products company Symbion CP Holdings Pty from Healius for 560M AUD

Acquisition Highlights
  • This is Sanofi’s 1st transaction in the Consumer Products sector.
  • This is Sanofi’s 14th largest (disclosed) transaction.
  • This is Sanofi’s 1st transaction in Australia.

M&A Deal Summary
Date 2008-07-21
Target Symbion CP Holdings Pty
Sector Consumer Products
Buyer(s) Sanofi
Sellers(s) Healius
Deal Type Divestiture
Deal Value 560M AUD

Target

Symbion CP Holdings Pty

Melbourne, Australia
Symbion CP Holdings Pty Ltd. manufactures, markets and distributes nutraceuticals (vitamins & mineral supplements) and over the counter brands throughout Australia and New Zealand. Symbion Consumer has a strong portfolio of premium brands including Natures Own, Cenovis, Bio-organics, Golden Glow and Microgenics.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sanofi

Paris, France
Category Company
Founded 1994
Sector Life Science
Employees82,878
Revenue 44.3B EUR (2024)
DESCRIPTION

Sanofi is a French multinational pharmaceutical company. Sanofi was founded in 1994 and is based in Paris, France.

DEAL STATS #
Overall 1 of 30
Sector: Consumer Products M&A 1 of 3
Type: Divestiture M&A Deals 1 of 3
Country: Australia M&A 1 of 1
Year: 2008 M&A 1 of 1
Size (of disclosed) 14 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-01-01 Sylachim S.A.

France

Sylachim S.A. manufactures and distributes fine chemicals and pharmaceutical active ingredients for production of drugs.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-04-09 Medley Indústria Farmacêutica

Campinas, Brazil

Medley is the third largest pharmaceutical company and the number one generic company in Brazil. The company is the major generic player and the third largest pharmaceutical company in Brazil with a total 5.7% market share and a CAGR - Compound Annual Growth Rate - of 28% over the last 3 years (IMS MAT Feb. 09). The portfolio is composed of 127 products, out of which 17 of the top 20 generics products in the market.

Buy €500M

Seller(S) 1

SELLER

Healius

Sydney, Australia
Category Company
Founded 1994
Sector Healthcare Services
Employees10,500
Revenue 1.7B AUD (2024)
DESCRIPTION

Healius offers a comprehensive range of services and facilities to general practitioners, specialists, and other healthcare providers who conduct their own practices and businesses at its medical centres, licensed day surgeries, specialist clinics, and dental clinics. Healius was founded in 1994 and is based in Sydney, Australia.

DEAL STATS #
Overall 1 of 4
Sector: Consumer Products M&A 1 of 1
Type: Divestiture M&A Deals 1 of 4
Country: Australia M&A 1 of 4
Year: 2008 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-01 Health Communication Network

St Leonards, Australia

Health Communication Network Ltd. is a provider of clinical and practice management software for clinicians in Australian.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-02-13 Healthscope - Queensland Pathology Assets

Melbourne, Australia

Healthscope's Queensland Pathology Assets is a provider of pathology services to public hospitals.

Buy -
Mergr

Solution for

Product

Company

Legal